TAK

Takeda Pharmaceutical Company Limited
D

TAK

13.100
USD
0.10
(0.77%)
مغلق
حجم التداول
63,927
الربح لكل سهم
139
العائد الربحي
4.72
P/E
23
حجم السوق
41,531,731,563
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AMGN
    AMGN
    2.27
    (0.87%)
    263.46 USD
    AZN
    AZN
    0.950
    (1.47%)
    65.370 USD
    GSK
    GSK
    0.155
    (0.46%)
    33.595 USD
    LLY
    LLY
    11.01
    (1.45%)
    768.44 USD
    MRK
    MRK
    -1.390
    (-1.40%)
    98.150 USD
    NVO
    NVO
    -18.485
    (-17.87%)
    84.980 USD
    PFE
    PFE
    0.595
    (2.31%)
    26.360 USD
    REGN
    REGN
    -5.64
    (-0.80%)
    702.60 USD
    SNY
    SNY
    0.170
    (0.36%)
    47.700 USD
    المزيد
الأخبار

العنوان: Takeda Pharmaceutical Company Limited

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.